Nifedipine Tablet, Extended Release
Product Images NDC 71610-689

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Nifedipine (NDC 71610-689). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 30 mg (71610 0689 30)

Nifedipine ER USP 30 mg extended-release tablets package label showing 30 tablets. The label includes storage instructions to keep between 20-25°C and in a tight-light-resistant container. It is labeled for prescription use only and manufactured by Novartis Laboratories Ltd, repackaged by Aphena Pharma Solutions - Tennessee, LLC.*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Image1 (Image 01)

Chemical structure diagram of nifedipine, showing its molecular framework including aromatic and heterocyclic rings with functional groups such as nitro, acetyl, and methoxy substituents.*

FDA Label Image

Image2 (Image 02)

A data table presenting mean reductions in trough supine systolic and diastolic blood pressure (mmHg) for nifedipine extended-release tablets. It includes results from two studies showing different doses (30 mg, 60 mg, 90 mg), sample sizes, and corresponding mean trough reductions with placebo response subtracted.*

FDA Label Image

Image3 (Image 03)

A table presenting the percentage of adverse effects reported for Nifedipine extended-release tablets and placebo groups. It lists headache, flushing/heat sensation, dizziness, fatigue/asthenia, nausea, and constipation, comparing their occurrence rates between 370 patients on Nifedipine and 126 patients on placebo.*

FDA Label Image

Image4 (Image 04)

A table listing nifedipine extended-release tablet strengths (30 mg, 60 mg, 90 mg) alongside their respective colors (yellow, pink, brown) and markings. Each tablet is marked with "Novast" on one side, with numbers "33", "36", or "39" on the other side corresponding to the strengths.*

FDA Label Image

Image6 (Image 06)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.